US EditionLAVA trial demonstrates high clinical success for EVOH - Interventional News
Summary by Interventional News
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
All
Left
Center
Right
LAVA trial demonstrates high clinical success for EVOH - Interventional News
Bulent Arslan Results from the prospective, multicentre Liquid Embolization of Arterial Haemorrhages in Peripheral Vasculature (LAVA) study evaluating the Lava (Sirtex) ethylene vinyl alcohol (EVOH) liquid embolic have demonstrated a 94.3% primary effectiveness rate, exceeding a clinical performance goal of 72%. “In the past five decades, many agents have been used in PAH [peripheral arterial haemorrhage], such as coils, plugs, particles, stent …
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
Ownership
To view ownership data please Upgrade to Vantage
